Indeed, the role of the CXCR2 pathway in obesity-induced inflammatory response was confirmed by the observation that a CXCR1/2 inhibitor was effective in the db/db mouse model in reducing neutrophil and macrophage infiltration in the liver and in the adipose tissue [42]. This evidence concerns the gene CXCR2 and obesity disorder.